Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Published Online: 2014-06-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Beatriz Grinsztejn•Breno Riegel Santos•Carla Vorsatz•Carlos Brites•Catherine Fagard•Constance Delaugerre•Geneviève Chêne•Jean-Michel Molina•José Henrique Pilotto•José Valdez Madruga•Marilia Santini-Oliveira•Mariza Morgado•Nathalie De Castro•Nêmora Tregnago Barcellos•Olivier Patey•Valdiléa G Veloso•Vincent Arnold
